ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FUM Futura Medical Plc

35.45
0.05 (0.14%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.14% 35.45 35.20 35.60 35.65 35.20 35.45 246,675 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.14 105.85M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.40p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £105.85 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.14.

Futura Medical Share Discussion Threads

Showing 20401 to 20421 of 21425 messages
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older
DateSubjectAuthorDiscuss
08/1/2024
08:49
Also the overhang from the last 6 months has cleared.See you at the 200p party
j777j
08/1/2024
08:43
Share price is telling you something.USA USA USA
j777j
08/1/2024
08:30
Eroxon is a game changer product that rivals Viagra without having to pop a pill.

Results are due in the weeks ahead and you only need to visit the Boots website to see that the product is flying off the shelves. Take a look at the online store and one can see It has recently been promoted and marketed as a top 5 best selling product for Boots! I think investors are finally going to see the pot of gold they have been waiting for.....(waiting for years might i add).

Review the historic highs and we were significantly higher during clinical trials. Eroxon is now a fully commercial product and the upside potential is vast especially from these lows.

Mark this message because I think we are going to see a strong rise in the weeks ahead. I mean 3-5x current share price

eyeofthetiger
08/1/2024
08:10
have a mate who tried it and is over the moon with and swears by it
goldie40
08/1/2024
08:04
Ladies and gentlemen we seem to have liftoff at long last
wheeze
08/1/2024
05:23
Do we have any testimonies from any advfn contributors with actual ED - given it is quite cheap one would hope some have at least tried it by now.

Or more simply does anyone know of any mates who have tried it ? If you do not have ED to go out and buy the product to prove the efficacy seems a bit of a waste of money if the information is out there? Perhaps some clever souls have already done this and are keeping the info quiet :)

takeiteasy
08/1/2024
04:14
Also posted on LSE........"The record-breaking launch of Eroxon"https://www.ceutagroup.com/success-stories/eroxon-stimgel/
broomrigg
07/1/2024
16:10
Posted today over on LSE......

"Mark this day 07/01/2024.

If correct on the Boots website the 4 pack s showing as the BESTSELLER!

BOOM!

And the two x 4 pack as the 5th bestseller.

F YR figs to 31/12/2023 will be done.

The horse may well have bolted!"

broomrigg
06/1/2024
14:30
Yes, well some positive sales numbers might help cure that trend. In the mean time the share price is low so any good news, especially on progress in the US, could at least get us away from these disappointing levels.
broomrigg
06/1/2024
14:01
Leaky or FOMO? The trouble with leaks of good news, which we've seen before, is that by the time the news is actually released, the price has been built in, and then we see it slowly decline until the next time. Still, any rise is better than none, as the actress said to the bishop!
petroc
05/1/2024
16:40
Yes sales look like they've picked-up on Amazon (and Boots)..... and defo looked leaky at the end there.
broomrigg
05/1/2024
16:06
Seems news has leaked see you all at 200p
j777j
05/1/2024
09:47
amazon

Eroxon


#1 Best Seller in Male Condoms

j777j
04/1/2024
18:44
I hear Kier Starmer has been prescribed Eroxon, to help him get an election...
wheeze
04/1/2024
15:17
US launch on the way see you at 200p a share
j777j
04/1/2024
15:12
New us centric ad has had 1.2 million views in 2 days



Fasten seatbelts 2024 is the year

j777j
04/1/2024
13:25
The proof of the pudding is in the eating, and as Boots awarded Eroxon 'Product of the Year' last year, they obviously disbelieved the clearly contrived* negative reviews.
'*Clearly contrived' as stated by James Barder.

petroc
04/1/2024
12:01
"Boots website have never seen so many 'thumbs up' to negative reviews, and so many 'thumbs down' to positives, so they know something is amiss."

Proof?

glavey
04/1/2024
07:21
That's made a mockery of the clinical trials
jailbird
04/1/2024
05:39
Eroxon: 322 out of 428 (75.23%) reviewers don't recommend this product
glavey
02/1/2024
12:49
Futura won an award for spending the best big budget on marketing Eroxon. And since Eroxon only launched in April 2023 they managed to spend the over £0.5 million required in marketing in an even shorter period. Just between April 2023 - August 2023.htTPs://www.citeline.com/en/awards/otcmarketingawardsBEST BIG BUDGET OTC MARKETING CAMPAIGNThis Award is designed for big-budget OTC brands which have been supported by a total marketing spend – both above-the-line and below-the – line – exceeding £0.5 million between August 2022 – August 2023WINNEREroxon, Futura Medical
mdi
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older

Your Recent History

Delayed Upgrade Clock